BG

Bellevue Group Portfolio holdings

AUM $4.54B
1-Year Est. Return 22.5%
This Quarter Est. Return
1 Year Est. Return
+22.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.54B
AUM Growth
+$74.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
155
New
Increased
Reduced
Closed

Top Buys

1 +$39.2M
2 +$38.3M
3 +$36.5M
4
TMO icon
Thermo Fisher Scientific
TMO
+$20M
5
EWTX icon
Edgewise Therapeutics
EWTX
+$17.7M

Top Sells

1 +$35.5M
2 +$29.9M
3 +$25.6M
4
BSX icon
Boston Scientific
BSX
+$20M
5
COR icon
Cencora
COR
+$19M

Sector Composition

1 Healthcare 99.88%
2 Technology 0.01%
3 Consumer Discretionary 0.01%
4 Communication Services 0.01%
5 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARGX icon
1
argenx
ARGX
$50.9B
$315M 6.94%
571,039
-7,835
IONS icon
2
Ionis Pharmaceuticals
IONS
$11.6B
$310M 6.84%
7,853,198
NBIX icon
3
Neurocrine Biosciences
NBIX
$13.7B
$229M 5.04%
1,820,000
ALNY icon
4
Alnylam Pharmaceuticals
ALNY
$63.9B
$221M 4.86%
676,367
-91,780
ABT icon
5
Abbott
ABT
$222B
$213M 4.69%
1,564,022
+7,893
SYK icon
6
Stryker
SYK
$141B
$212M 4.67%
535,089
-31,508
ISRG icon
7
Intuitive Surgical
ISRG
$158B
$206M 4.54%
378,728
-47,018
VRTX icon
8
Vertex Pharmaceuticals
VRTX
$105B
$197M 4.33%
441,610
+28,539
BSX icon
9
Boston Scientific
BSX
$146B
$190M 4.18%
1,765,194
-185,826
RVMD icon
10
Revolution Medicines
RVMD
$10.4B
$168M 3.71%
4,579,300
+205,000
AGIO icon
11
Agios Pharmaceuticals
AGIO
$2.51B
$119M 2.63%
3,590,150
+75,000
INCY icon
12
Incyte
INCY
$17.2B
$107M 2.36%
1,570,333
-521,447
AKRO icon
13
Akero Therapeutics
AKRO
$4.3B
$106M 2.33%
1,985,272
+734,606
SRRK icon
14
Scholar Rock
SRRK
$2.78B
$104M 2.3%
2,947,295
+440,405
MDT icon
15
Medtronic
MDT
$122B
$80.3M 1.77%
921,043
-17,312
IMCR icon
16
Immunocore
IMCR
$1.68B
$76.6M 1.69%
2,441,830
+1,220,036
DXCM icon
17
DexCom
DXCM
$25.9B
$75.1M 1.66%
860,828
-203,280
EW icon
18
Edwards Lifesciences
EW
$43B
$69.5M 1.53%
889,077
-82,892
PODD icon
19
Insulet
PODD
$22.4B
$68.8M 1.52%
219,013
-52,273
CLDX icon
20
Celldex Therapeutics
CLDX
$1.76B
$67.3M 1.48%
3,307,569
+235,954
BDX icon
21
Becton Dickinson
BDX
$53.2B
$54.6M 1.2%
316,732
-27,579
BEAM icon
22
Beam Therapeutics
BEAM
$2.64B
$49.1M 1.08%
2,889,288
+493,358
TMO icon
23
Thermo Fisher Scientific
TMO
$203B
$46M 1.01%
113,544
+49,312
PEN icon
24
Penumbra
PEN
$9.87B
$44.7M 0.98%
174,050
-30,467
UNH icon
25
UnitedHealth
UNH
$321B
$44.4M 0.98%
142,296
-22,446